Furthermore, TRPV1 was upregulated in uveal melanoma cells suggesting that TRPM8 is a potential drug target for suppressing VEGF-induced increases in neovascularization and uveal melanoma growth. This evidence concerns the gene VEGFA and uveal melanoma.